Preclinical results suggest that delivery of the atonal gene using GenVec’s innovative adenovector technology may have the potential to restore hearing and balance function. As per the agreement,
Walter Weller, president and COO of MedPro, said: “The Insulin Guard meets a significant need in the home healthcare market for a truly passive safety self-injector that can
The company claims that the samples will be processed at Interleukin Genetics’ CLIA-certified laboratory in Waltham, MA and will receive royalties and processing fees for each test sold.
Under the collaboration, Affomix is expected to use its automated antibody selection technology to provide City of Hope with recombinant antibodies that are designed to be readily tagged
Matthew Schissler, co-founder and CEO of CBAI, said: “This is another very important step forward for Cord Blood America. “As a direct result of processing and storing cord
Per Walday, CEO of PCI Biotech, said: “We are very excited by the positive results that have been reported from University College Hospital (UCH) in London. The strong
Reportedly, the Center’s new pilot production facility is nearing completion. Following the engineering test runs and facility validation to ensure FDA quality standards are met, production of product
Chang Ahn, chairman and chief executive officer of Rexahn, said: “In addition to our co-development partnership with Teva, this European patent award further validates the commercial potential of
Pamidronate disodium is indicated for the treatment of moderate or severe hypercalcemia associated with malignancy, with or without bone metastases. Patients who have either epidermoid or non-epidermoid tumors
As per the agreement, Idera is entitled to receive a payment of E3m from Merck. The company is expects to receive the milestone payment during the first quarter
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.